Dr. Matthew Reed and Dr. C. Michael Gibson discuss: ASPIRED: Multi-centre open label randomised controlled trial of immediate enhanced ambulatory ECG monitoring versus standard monitoring in acute unexplained syncope patients September 11, 2026 Disclosures: TBD
Dr. Maria Back and Dr. C. Michael Gibson discuss: Remote Exercise SWEDEHEART: a cluster randomized cross-over trial on cardiac telerehabilitation September 10, 2026 Disclosures: TBD
The intersection of cancer care and cardiovascular health is rapidly evolving. Dr. Novi Yanti Sari and Dr. C. Michael Gibson discuss key developments, emerging therapies, and what’s next for the field September 1, 2026 Disclosures: TBD
Dr. Viktor Kocka and Dr. Josef Kroupa and Dr. C. Michael Gibson discuss: Prague 26: catheter-directed thrombolysis for pulmonary embolism August 31, 2026 Disclosures: TBD
Dr. Lente Pol and Dr. C. Michael Gibson discuss: CAG after OHCA without ST-elevation August 31, 2026 Disclosures: TBD
Dr. Sten Rubertsson and Dr. C. Michael Gibson discuss: DISCO trial: Acute coronary angiography after resuscitated out-of-hospital cardiac arrest without ST-elevation on the ECG August 31, 2026 Disclosures: TBD
Dr. Keyur Vora and Dr. C. Michael Gibson discuss: Intravenous Dexrazoxane for Hemorrhagic Myocardial Infarction in STEMI: A Double-Blind, Placebo-Controlled, Sequential-Cohort Phase IIa Trial (SHIELD-MI) August 31, 2026 Disclosures: TBD
Dr. Marat Fudim and Dr. C. Michael Gibson discuss: Outcomes of Intracoronary AAV1/SERCA2a Gene Therapy in Patients With Heart Failure With Preserved Ejection Fraction: 12-Month Results From the MUSIC-HFpEF Phase 1/2a Trial August 31, 2026 Disclosures: TBD
Dr. Steven Nissen and Dr. C. Michael Gibson discuss: Effect on Oxidized Phospholipids of Lepodisiran, an Extended Duration siRNA Targeting Lipoprotein(a) August 31, 2026 Disclosures: TBD
Dr. Michael Vinther and Dr. C. Michael Gibson discuss: HIS Alternative II August 31, 2026 Disclosures: TBD
